1. Home
  2. CABA vs XPOF Comparison

CABA vs XPOF Comparison

Compare CABA & XPOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CABA
  • XPOF
  • Stock Information
  • Founded
  • CABA 2017
  • XPOF 2017
  • Country
  • CABA United States
  • XPOF United States
  • Employees
  • CABA N/A
  • XPOF N/A
  • Industry
  • CABA Biotechnology: Biological Products (No Diagnostic Substances)
  • XPOF Services-Misc. Amusement & Recreation
  • Sector
  • CABA Health Care
  • XPOF Consumer Discretionary
  • Exchange
  • CABA Nasdaq
  • XPOF Nasdaq
  • Market Cap
  • CABA 260.7M
  • XPOF 302.9M
  • IPO Year
  • CABA 2019
  • XPOF 2021
  • Fundamental
  • Price
  • CABA $2.45
  • XPOF $6.89
  • Analyst Decision
  • CABA Strong Buy
  • XPOF Buy
  • Analyst Count
  • CABA 8
  • XPOF 8
  • Target Price
  • CABA $11.63
  • XPOF $12.31
  • AVG Volume (30 Days)
  • CABA 5.1M
  • XPOF 477.4K
  • Earning Date
  • CABA 11-13-2025
  • XPOF 11-06-2025
  • Dividend Yield
  • CABA N/A
  • XPOF N/A
  • EPS Growth
  • CABA N/A
  • XPOF N/A
  • EPS
  • CABA N/A
  • XPOF N/A
  • Revenue
  • CABA N/A
  • XPOF $316,841,000.00
  • Revenue This Year
  • CABA N/A
  • XPOF N/A
  • Revenue Next Year
  • CABA N/A
  • XPOF $2.86
  • P/E Ratio
  • CABA N/A
  • XPOF N/A
  • Revenue Growth
  • CABA N/A
  • XPOF N/A
  • 52 Week Low
  • CABA $0.99
  • XPOF $6.64
  • 52 Week High
  • CABA $5.46
  • XPOF $18.87
  • Technical
  • Relative Strength Index (RSI)
  • CABA 50.01
  • XPOF 32.19
  • Support Level
  • CABA $2.77
  • XPOF $6.64
  • Resistance Level
  • CABA $3.01
  • XPOF $7.19
  • Average True Range (ATR)
  • CABA 0.37
  • XPOF 0.43
  • MACD
  • CABA -0.03
  • XPOF -0.06
  • Stochastic Oscillator
  • CABA 19.36
  • XPOF 14.97

About CABA Cabaletta Bio Inc.

Cabaletta Bio Inc is a clinical-stage biotechnology company focused on the discovery and development of engineered T cell therapies and exploring their potential to provide a deep and durable, perhaps curative, treatment for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes Chimeric AutoAntibody Receptor, or CAART cells, that are designed to selectively bind and eliminate only specific B cells that produce disease-causing autoantibodies, or pathogenic B cells, while sparing normal B cells. Its CABA platform encompasses two strategies: CARTA (chimeric antigen receptor T cells for autoimmunity) and CAART (chimeric autoantibody T cells) that have the potential to be applied across a broad range of autoimmune diseases.

About XPOF Xponential Fitness Inc.

Xponential Fitness Inc is a curator of boutique fitness brands. Its diversified portfolio of brands includes Club Pilates, a Pilates brand in the United States; CycleBar, an indoor cycling brand in the United States; StretchLab, a concept offering one-on-one and group stretching services; Row House, a high-energy, low-impact indoor rowing workout; AKT, a dance-based cardio workout combining toning, interval and circuit training; YogaSix a franchised yoga brand; Pure Barre, a total body workout that uses the ballet barre to perform small isometric movements; Stride, a treadmill-based cardio and strength training concept; Rumble, a boxing-inspired full-body workout; and BFT, a functional training and strength-based program. Its key revenue source is franchise income.

Share on Social Networks: